The UK product information notes that semaglutide caused C-cell tumours in rodents (though the human relevance is uncertain) and advises monitoring for thyroid symptoms, especially with pre-existing thyroid disease
2020;53(1):e13644
Zepbound para manejo de peso) es un agonista dual GLP-1/GIP ms reciente que, en estudios como SURPASS-2, ha mostrado eficacia an mayor que semaglutida, pero la semaglutida tiene ms datos de seguridad a largo plazo
In addition to Equazen Pro Jelly Chews, ConCordix Smart Chews are available in a growing list of formulas including omega-3s and multivitamins, immune and vision health
Patients with government insurance should verify alternative access pathways
A major breakthrough in 2023 was the introduction of glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist tirzepatide, which activates both receptors and has shown superior glucose-lowering and weight-reducing effects in both clinical trials and real-world Japanese settings